Clarke Neumann - 15 Aug 2023 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIORQ)

Role: Senior Vice President, General Counsel and Secretary
Signature: /s/ Clarke Neumann
Issuer symbol: BIORQ
Transactions as of: 15 Aug 2023
Net transactions value: -$113,615
Form type: 4
Filing time: 17 Aug 2023, 16:27:25 UTC
Previous filing: 17 May 2023
Next filing: 15 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIOR	Common Stock	Tax liability	$113,615	-36,183	-41%	$3.14	52,018	15 Aug 2023	Direct	F1
transaction	BIOR	Common Stock	Award	$0	+210,175	+404%	$0.000000	262,193	15 Aug 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested RSUs.
F2	Consists of 210,175 restricted stock units, 25% of which will vest on August 15, 2024, with the remaining shares vesting in equal semi-annual installments through August 15, 2027, subject to the Reporting Person's continued service to the Issuer.

Remarks:

Senior Vice President, General Counsel and Secretary